17th Annual Wall Street Analyst Forum Presenter Profiles.

NEW YORK -- The 17th Annual Wall Street Analyst Forum takes place June 14-16, 2006, in New York. For in-depth information about the event visit http://www.analyst-conference.com/. Below are profiles from 17th Annual Wall Street Analyst Forum presenters.

Business Wire is the official news wire for 17th Annual Wall Street Analyst Forum. Breaking news releases and photos are available at http://www.tradeshownews.com, Business Wire's trade show, conference, and event news resource.

Company: Biopure Corporation
Ticker Symbol & Exchange: Nasdaq: BPUR
Investor Relations Contact: Douglas Sayles, Director, Corporate
                             Communications
Investor Relations Contact Phone: [phone]
Web: www.biopure.com
Date of Presentation: 06/14/2006

Biopure Corporation produces pharmaceuticals called oxygen
therapeutics that are intravenously administered to deliver oxygen to
the body's tissues. Hemopure(R) (hemoglobin glutamer - 250 (bovine))
is commercially available in South Africa for the treatment of acute
surgical anemia. Biopure plans to apply in Europe, in mid 2006, for a
potential surgical anemia indication. The company is developing
Hemopure for cardiovascular ischemia and is supporting the U.S. Navy's
government-funded efforts to develop the product for out-of-hospital
trauma. The company's veterinary product Oxyglobin(R) (hemoglobin
glutamer - 200 (bovine)) is commercially available in the U.S. and
E.U. for the treatment of anemia in dogs.

Company: Black Hills Corporation
Ticker Symbol & Exchange: NYSE: BKH
Investor Relations Contact: Dale Jahr
Investor Relations Contact Phone: [phone]
Web: blackhillscorp.com
Date of Presentation: June 16, 2006

Black Hills Corporation is a diversified energy Company. Long-term
growth and shareholder value are expected through our strengths as a
competitive energy producer and reliable service provider. Dividends
have increased for 36 consecutive years.

Cheyenne Light, Fuel and Power serves 32,500 gas and 38,700
electric customers in Wyoming. Black Hills Power serves 63,500
customers primarily in western South Dakota. Wholesale energy includes
power generation (1,000 MW), natural gas and oil (13.7 Bcfe
production; 170 Bcfe reserves), coal (4.7 MMT production; 290 MMT
reserves), and energy marketing. Our diversified energy businesses
provide a strong foundation for our future, as we seek to grow in
risk-managed and balanced ways.

Company: Coeur d'Alene Mines Corporation
Ticker Symbol & Exchange: NYSE: CDE TSX: CDM
Investor Relations Contact: Scott Lamb
Investor Relations Contact Phone: [phone]
Web: www.coeur.com
Date of Presentation: June 16, 2006

Coeur d' Alene Mines Corporation is the world's largest publicly
traded primary silver producer and has a strong presence in gold. In
2005, the Company produced almost 14 million ounces of silver and more
than 130,000 ounces of gold at a cash operating cost of approximately
$4.26 per ounce of silver. Coeur has five operating mines (in
Argentina, Australia(2), Chile, and Nevada) and two mines under
construction (in Bolivia and Alaska). With a market cap of
approximately $1.5 billion, Coeur has the strongest balance sheet in
the sector and daily trading volumes of more than 10 million shares.

Company: Commonwealth Biotechnologies, Inc
Ticker Symbol & Exchange: CBTE
Investor Relations Contact: Dr. Robert B. Harris
Investor Relations Contact Phone: [phone]
Web: www.cbi-biotech.com
Date of Presentation: 6/14/06

Commonwealth Biotechnologies, Inc. is a solutions provider to the
global biotechnology industry, academic institutions, government
agencies, and pharmaceutical companies. CBI offers broad ranging
expertise and a complete array of the most current analytical and
synthetic chemistries and biophysical analysis technologies, many of
which are not available from other commercial sources. CBI has crafted
a stimulating, open environment where scientists collaborate among
themselves and, with our clients, take on interesting challenges and
develop creative solutions. Through its Fairfax Identity Labs ("FIL")
division, CBI offers comprehensive genetic identity testing, including
paternity, forensic, and Convicted Offender DNA Index System ("CODIS")
analyses.

Company: Deutsche Telekom
Ticker Symbol & Exchange: NYSE: DT
Investor Relations Contact: Nils Paellmann
Investor Relations Contact Phone: [phone]
Web: http://www.telekom.de/investor-relations
Date of Presentation: Thursday, June 15, 2006, 9:10 am

Deutsche Telekom (NYSE: DT) is one of the world's leading
telecommunications companies and parent company of T-Mobile. DT offers
millions of private and corporate customers in Europe and the US the
entire spectrum of modern information technology and
telecommunications services. DT is focused on three main growth areas
in the industry - Broadband/Fixed-network, Business Customers and
Mobile Communications. DT recently paid a dividend of US$0.91 per
share for the year 2005, representing a dividend yield of 5.4%.

Company: FX Energy, Inc.
Ticker Symbol & Exchange: Nasdaq: FXEN
Investor Relations Contact: Scott J. Duncan
Investor Relations Contact Phone: [phone]
Web: www.fxenergy.com
Date of Presentation: June 16, 2006

FX Energy, Inc. holds a land position of over 1.7 million acres in
a known hydrocarbon region in western Poland's Permian Basin. The
Permian Basin's gas-bearing Rotliegend sandstone is a direct analog to
the Southern Gas Basin offshore England, and represents a largely
untapped source of potentially significant gas reserves. FX Energy is
exploiting this untapped potential in the belief that it can create
substantial growth in oil and gas reserves and cash flow for its
stockholders.

Company: OMNOVA Solutions Inc.
Ticker Symbol & Exchange: OMN, NYSE
Investor Relations Contact: Michael Hicks
Investor Relations Contact Phone: [phone]
Web: www.omnova.com
Date of Presentation: June 14, 2006

OMNOVA Solutions designs and manufactures decorative and
functional surfaces and specialty chemicals for a number of end use
markets, including a significant presence in the building materials
and products sector. The company is a leading global supplier of
commercial wallcoverings, coated upholstery fabrics, laminates,
single-ply commercial roofing systems, polymer coatings and
performance chemical additives. Headquartered in Fairlawn, Ohio,
OMNOVA Solutions had 2005 sales of $810 million. The current workforce
numbers about 1,800 employees worldwide.

Company: Polaris Minerals Corporation
Ticker Symbol & Exchange: PLS - Toronto Stock Exchange
Investor Relations Contact: Marlene Mathison
Investor Relations Contact Phone: [phone] ext. 104
Web: www.polarmin.com
Date of Presentation: June 14th at 11:50am

Polaris Minerals Corporation (TSX: PLS), based in Vancouver,
British Columbia, Canada is exclusively focused on supplying
construction aggregates from two properties located on Vancouver
Island, British Columbia, to coastal urban markets on the western
seaboard of North America. Polaris is targeting markets where
accelerating local supply deficits and increasing road distribution
costs enable marine transported aggregates to be competitive in the
heart of major coastal urban markets.

In addition to its aggregates properties, Polaris owns a 70%
interest in the rights to construct and operate a marine receiving and
discharge terminal in the Port of Richmond, San Francisco Bay. Polaris
has also executed a long-term freight contract with CSL International
that is the key to the cost-effective bulk-shipping of construction
aggregates to California.

Company: PrimeWest Energy
Ticker Symbol & Exchange: PWI (NYSE), PWI.un (TSX)
Investor Relations Contact: George Kesteven
Investor Relations Contact Phone: [phone]
Web: www.primewestenergy.com
Date of Presentation: June 16th, 2006

PrimeWest is a Calgary, Alberta, Canada based conventional oil and
gas royalty trust that actively acquires, develops, produces and sells
natural gas, crude oil and natural gas liquids for the generation of
monthly cash distributions to Unitholders. The Trust's operations are
focused on the Western Canadian Sedimentary Basin, primarily in
Alberta. Since inception in 1996, production has grown from 9,600
BOE/day to over 38,000 BOE/day during the first quarter of 2006.

Trust Units of PrimeWest are traded on the Toronto Stock Exchange
(TSX) under the symbol "PWI.UN" and on the New York Stock Exchange
(NYSE) under the symbol "PWI". Exchangeable shares of PrimeWest Energy
are listed on the TSX under the Symbol "PWX". Five year Convertible
Debentures of PrimeWest trade on the TSX under the symbol "PWI.DB.A"
and the Seven-year Convertible Debentures trade under the symbol
"PWI.DB.B".

Company: pSivida Limited
Ticker Symbol & Exchange: PSDV
Investor Relations Contact: Brian Leedman
Investor Relations Contact Phone: [phone]
Web: www.psivida.com
Date of Presentation: 14 June 2006

pSivida is a global bio-nanotech company committed to the
development of drug delivery products in the healthcare sector,
initially in ophthalmology and oncology.

pSivida has four evaluation agreements for the Company's drug
delivery technologies with three of the five largest pharmaceutical
companies in the world. pSivida recently announced a further
evaluation agreement with an undisclosed global medical device company
to evaluate cardiovascular delivery of drugs using pSivida's drug
delivery technologies.

Company: Questcor Pharmaceuticals, Inc.
Ticker Symbol & Exchange: QSC
Investor Relations Contact: Eric Liebler
Investor Relations Contact Phone: [e-mail] 908-437-1320
Web: www.questcor.com
Date of Presentation: June 14, 2006

Questcor Pharmaceuticals, Inc.(R) (AMEX: QSC) is a specialty
pharmaceutical company that develops and commercializes novel
therapeutics for the treatment of neurological disorders. Questcor
currently markets H.P. Acthar(R) Gel (repository corticotropin
injection), an injectable drug indicated for the treatment of
exacerbations associated with Multiple Sclerosis and Doral(R)
(quazepam) that is indicated for the treatment of insomnia,
characterized by difficulty in falling asleep, frequent nocturnal
awakenings, and/or early morning awakenings. For more information,
please visit www.questcor.com.

Company: Somanta Pharmaceuticals
Investor Relations Contact: Don Markley
Investor Relations Contact Phone: [phone]
Web: www.somanta.com
Date of Presentation: June 14, 2006

Somanta Pharmaceuticals, Inc. is an oncology company focused on
in-licensing anti-cancer agents with substantial clinical data
supporting safety and efficacy for further clinical development. To
date the company has licensed rights to five products (three small
molecules and two monoclonal antibodies), each with a different
mechanism of action and targeting 12 different cancer types. On
January 31, 2006, Somanta merged with Hibshman Optical, a publicly
reporting company with no prior operating or stock trading history.
In January 2006 Somanta received approximately $5.9 million in gross
proceeds from the sale of Series A convertible preferred stock to a
group of institutional investors.

Company: Talisman Energy Inc.
Ticker Symbol & Exchange: TLM - TSX, NYSE
Investor Relations Contact: Christopher LeGallais
Investor Relations Contact Phone: [phone]
Web: www.talisman-energy.com
Date of Presentation: June 16, 2006

Talisman Energy Inc. is a large, independent oil and gas producer
with operations in Canada, the North Sea, Southeast Asia and
Australia, North Africa, United States and Trinidad and Tobago.
Talisman's subsidiaries also conduct business in Colombia, Gabon,
Peru, Romania and Qatar.

Talisman is a C$28 billion company (approximate enterprise value
at May 10, 2006), employing over 2,100 people, with headquarters in
Calgary, Canada.

Over the past 14 years, Talisman has grown production per share at
an average compound annual rate of 11%. A core strength of the Company
is its technical and commercial expertise. At year end, Talisman had
1.6 billion boe's of high quality proved reserves (55% natural gas,
45% high quality oil and liquids).

Company: ZIOPHARM Oncology Inc.
Ticker Symbol & Exchange: ZIOP.OB
Investor Relations Contact: Suzanne McKenna
Investor Relations Contact Phone: [phone]
Web: www.ziopharm.com
Date of Presentation: June 14, 2006 9:50 am

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in
the development and commercialization of a diverse, risk-sensitive
portfolio of in-licensed cancer drugs to address unmet medical needs.
The Company applies new insights from molecular and cancer biology to
understand the efficacy and safety limitations of approved and
developmental cancer therapies and identifies proprietary and related
molecules for better patient treatment. For more information, visit
www.ziopharm.com.

Note to Editors: Business Wire's PressPass allows you to create free, custom Web, RSS, and email-based news feeds from more than 160 industry options, dozens of subject categories and thousands of geographic preferences as well as by specific company filters. In addition, PressPass subscribers have access to exclusive content, experts, company profiles, email alerts, survey services and other media services.

Note to Event Organizers: Add your trade show, conference, or event to www.tradeshownews.com, Business Wire's online event calendar. For information, email [e-mail].